March 2020 FDA Recall Drug by Fresenius Medical Care Holdings, Inc.
D-1064-2020 - CGMP Deviation

This Class II drug recall was voluntarily initiated by Fresenius Medical Care Holdings, Inc. on March 5, 2020 for the product Drug. The FDA reported the reason for recall as cgmp deviation. The product was distributed in Product was distributed throughout the United States. and the recall is currently terminated.

Recall Number: D-1064-2020

Reason for Recall
CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.
Initiated
03-05-2020
Reported
03-25-2020
Quantity
32,592 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Medical Care Holdings, Inc.
Product was distributed throughout the United States.
Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451

Batch or Lot Expiration Information

Lot# : 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020